WHOLE-EXOME SEQUENCING OF MONOZYGOTIC TWINS WITH EPILEPSY AND AUTISM SPECTRUM DISORDER IN A KAZAKHSTANI FAMILY: A CASE REPORT
Main Article Content
Authors
A.K.
Gabdulkayum
Laboratory of Genomic and Personalized Medicine, Center for Life Sciences, PI “National Laboratory Astana”, Kabanbay batyr Avenue 53, Astana, 010000, Kazakhstan.
Zh.Zh.
Mirmanova
Laboratory of Genomic and Personalized Medicine, Center for Life Sciences, PI “National Laboratory Astana”, Kabanbay batyr Avenue 53, Astana, 010000, Kazakhstan.
A.Zh.
Daniyarov
Laboratory of Bioinformatics and Systems Biology, Center for Life Sciences, PI ”National Laboratory Astana”, Kabanbay batyr Avenue 53, Astana, 010000, Kazakhstan
Institute of Cell Biology and Biotechnology, L.N. Gumilyov Eurasian National University, Astana, 01000, Kazakhstan
N.N.
Satvaldina
Laboratory of Genomic and Personalized Medicine, Center for Life Sciences, PI “National Laboratory Astana”, Kabanbay batyr Avenue 53, Astana, 010000, Kazakhstan
A.S.
Kudaibergenov
NJSC ”National Center for Children’s Rehabilitation”, Turan Avenue 36, Astana, 010000, Kazakhstan
Zh.A.
Medetbekova
NJSC ”National Center for Children’s Rehabilitation”, Turan Avenue 36, Astana, 010000, Kazakhstan.
S.
Amangeldikyzy
NJSC ”National Center for Children’s Rehabilitation”, Turan Avenue 36, Astana, 010000, Kazakhstan.
A.
Giniyat
NJSC ”National Center for Children’s Rehabilitation”, Turan Avenue 36, Astana, 010000, Kazakhstan.
A.R.
Akilzhanova
Laboratory of Genomic and Personalized Medicine, Center for Life Sciences, PI “National Laboratory Astana”, Kabanbay batyr Avenue 53, Astana, 010000, Kazakhstan
D.A.
Yerezhepov
Laboratory of Genomic and Personalized Medicine, Center for Life Sciences, PI “National Laboratory Astana”, Kabanbay batyr Avenue 53, Astana, 010000, Kazakhstan
Abstract
Epilepsy and autism spectrum disorder (ASD) frequently co-occur and share complex genetic determinants. However, molecular diagnosis remains challenging because of incomplete penetrance, variable expressivity, and the limited representation of Central Asian populations in genomic reference databases. This case report describes a Kazakhstani family with 9-year-old monozygotic twin girls who developed focal seizures with secondary generalization at approximately one year of age and were subsequently diagnosed with ASD. Family-based whole-exome sequencing was performed for both affected twins and their clinically unaffected, non-consanguineous parents. No pathogenic or likely pathogenic variant explaining the shared epilepsy–ASD phenotype was identified. A paternally inherited NPRL3 missense variant, c.121A>G (p.Lys41Glu), was considered biologically plausible because of the established association of NPRL3 with focal epilepsy. However, it remained a variant of uncertain significance (VUS), was not reported in the queried gnomAD dataset, and had an AlphaMissense score of 0.14. Additional heterozygous VUS were identified in SPTBN4, ANK2, VPS33A, SLC25A46, and GFM1. Two ZC2HC1C variants inherited from different parents supported a possible biallelic hypothesis, but their clinical significance was uncertain. We interpreted a heterozygous pathogenic ALDOB variant as an incidental carrier finding unrelated to the presenting phenotype. This case illustrates the distinction between candidate variants and a molecular diagnosis. Further evaluation may include periodic exome reanalysis, copy-number analysis, genome sequencing, and targeted validation where justified. Broader population reference resources could improve variant interpretation in Kazakhstan.
Keywords
Epilepsy, autism spectrum disorder, whole-exome sequencing
Article Details
References
Fisher R.S., et al. Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) // Epilepsia. – 2005. – № 46(4). – P. 470–472.
Thijs R.D., et al. Epilepsy in adults // The Lancet. – 2019. – № 393(10172). – P. 689–701.
Beghi E. The Epidemiology of Epilepsy // Neuroepidemiology. – 2020. – № 54(2). – P. 185–191.
Beghi E., et al. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 // Lancet Neurology. – 2019. – № 18(4). – P. 357–375.
Blume W.T., et al. Glossary of Descriptive Terminology for Ictal Semiology: Report of the ILAE Task Force on Classification and Terminology // Epilepsia. – 2001. – № 42(9). – P. 1212–1218.
Staley K. Molecular mechanisms of epilepsy // Nature Neuroscience. – 2015. – № 18(3). – P. 367–372.
Symonds J.D., et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort // Brain. – 2019. – № 142(8). – P. 2303–2318.
Hildebrand M.S., et al. Recent advances in the molecular genetics of epilepsy // Journal of Medical Genetics. – 2013. – № 50(5). – P. 271–279.
Ellis C.A., Petrovski S., Berkovic S.F. Epilepsy genetics: clinical impacts and biological insights // Lancet Neurology. – 2020. – № 19(1). – P. 93–100.
Besag F. Epilepsy in patients with autism: links, risks and treatment challenges // Neuropsychiatric Disease and Treatment. – 2017. – № 14. – P. 1–10.
Lukmanji S., et al. The co-occurrence of epilepsy and autism: A systematic review // Epilepsy & Behavior. – 2019. – № 98. – P. 238–248.
Combi R., et al. Clinical and genetic evaluation of a family showing both autism and epilepsy // Brain Research Bulletin. – 2010. – № 82(1–2). – P. 25–28.
Sheidley B.R., et al. Genetic testing for the epilepsies: A systematic review // Epilepsia. – 2022. – № 63(2). – P. 375–387.
Balestrini S., et al. Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies // Journal of Neurology, Neurosurgery & Psychiatry. – 2021. – № 92(10). – P. 1044–1052.
Dixon-Salazar T.J., et al. Autism in Several Members of a Family With Generalized Epilepsy With Febrile Seizures Plus // Journal of Child Neurology. – 2004. – № 19(8). – P. 597–603.
Bayanova M., et al. Whole-Genome Sequencing Among Kazakhstani Children with Early-Onset Epilepsy Revealed New Gene Variants and Phenotypic Variability // Molecular Neurobiology. – 2023. – № 60(8). – P. 4324–4335.
Kairov U., et al. Whole-Genome Sequencing and Genomic Variant Analysis of Kazakh Individuals // Frontiers in Genetics. – 2022. – № 13.
Serikzhan A., et al. Genomic landscape of the Great Steppe: Genetic variants in healthy Kazakh individuals // Scientific Data. – 2025. – № 12(1). – Article 1679.
Karczewski K.J., et al. The mutational constraint spectrum quantified from variation in 141,456 humans // Nature. – 2020. – № 581(7809). – P. 434–443.
Rentzsch P., et al. CADD: predicting the deleteriousness of variants throughout the human genome // Nucleic Acids Research. – 2019. – № 47(D1). – P. D886–D894.
Cheng J., et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense // Science. – 2023. – № 381(6664).
Wang C.-C., et al. βIV Spectrinopathies Cause Profound Intellectual Disability, Congenital Hypotonia, and Motor Axonal Neuropathy // The American Journal of Human Genetics. – 2018. – № 102(6). – P. 1158–1168.
Knierim E., et al. A recessive mutation in beta-IV-spectrin (SPTBN4) associates with congenital myopathy, neuropathy, and central deafness // Human Genetics. – 2017. – № 136(7). – P. 903–910.
Satterstrom F.K., et al. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism // Cell. – 2020. – № 180(3). – P. 568–584.e23.
Banerjee-Basu S., Packer A. SFARI Gene: an evolving database for the autism research community // Disease Models & Mechanisms. – 2010. – № 3(3–4). – P. 133–135.
Kondo H., et al. Mutation in VPS33A affects metabolism of glycosaminoglycans: a new type of mucopolysaccharidosis with severe systemic symptoms // Human Molecular Genetics. – 2016. – Article ddw377.
Pavlova E.V., et al. The lysosomal disease caused by mutant VPS33A // Human Molecular Genetics. – 2019. – № 28(15). – P. 2514–2530.
Abrams A.J., et al. Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder // Nature Genetics. – 2015. – № 47(8). – P. 926–932.
Charlesworth G., et al. SLC25A46 mutations underlie progressive myoclonic ataxia with optic atrophy and neuropathy // Movement Disorders. – 2016. – № 31(8). – P. 1249–1251.
Coenen M.J.H., et al. Mutant Mitochondrial Elongation Factor G1 and Combined Oxidative Phosphorylation Deficiency // New England Journal of Medicine. – 2004. – № 351(20). – P. 2080–2086.
Zhang H., et al. Clinical phenotypic and genotypic characterization of NPRL3-related epilepsy // Frontiers in Neurology. – 2023. – № 14.
Yang D., et al. Phenotypic and genotypic characterization of NPRL3-related epilepsy: Two case reports and literature review // Epilepsia Open. – 2024. – № 9(1). – P. 33–40.
Baldassari S., et al. The landscape of epilepsy-related GATOR1 variants // Genetics in Medicine. – 2019. – № 21(2). – P. 398–408.
Treccarichi S., et al. Investigating the Role of the Zinc Finger Protein ZC2HC1C on Autism Spectrum Disorder Susceptibility // Medicina (Kaunas). – 2025. – № 61(4). – Article 574.
Bruder C.E.G., et al. Phenotypically Concordant and Discordant Monozygotic Twins Display Different DNA Copy-Number-Variation Profiles // The American Journal of Human Genetics. – 2008. – № 82(3). – P. 763–771.
Zou H., et al. Diagnostic efficiency of exome-based sequencing in pediatric patients with epilepsy // Frontiers in Genetics. – 2025. – № 15.